Ab(C)(D133) Modified alpha CT1 Loaded Target Magnetic Mesoporous Silica Nano-Drugcarriers Can Sensitizes Glioma Cancer Stem Cells to TMZ and Have Therapeutic Potential on TMZ Resistant Glioblastoma | |
Jin Xingyi; Chi Guonan; Zhao Xin; Liu Naijie | |
刊名 | JOURNAL OF BIOMEDICAL NANOTECHNOLOGY |
2019 | |
卷号 | 15期号:7 |
关键词 | Glioblastoma TMZ Resistance Targeted Therapy Cx43 alpha CT1 |
ISSN号 | 1550-7033 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3511702 |
专题 | 吉林大学白求恩第三医院 |
推荐引用方式 GB/T 7714 | Jin Xingyi,Chi Guonan,Zhao Xin,et al. Ab(C)(D133) Modified alpha CT1 Loaded Target Magnetic Mesoporous Silica Nano-Drugcarriers Can Sensitizes Glioma Cancer Stem Cells to TMZ and Have Therapeutic Potential on TMZ Resistant Glioblastoma[J]. JOURNAL OF BIOMEDICAL NANOTECHNOLOGY,2019,15(7). |
APA | Jin Xingyi,Chi Guonan,Zhao Xin,&Liu Naijie.(2019).Ab(C)(D133) Modified alpha CT1 Loaded Target Magnetic Mesoporous Silica Nano-Drugcarriers Can Sensitizes Glioma Cancer Stem Cells to TMZ and Have Therapeutic Potential on TMZ Resistant Glioblastoma.JOURNAL OF BIOMEDICAL NANOTECHNOLOGY,15(7). |
MLA | Jin Xingyi,et al."Ab(C)(D133) Modified alpha CT1 Loaded Target Magnetic Mesoporous Silica Nano-Drugcarriers Can Sensitizes Glioma Cancer Stem Cells to TMZ and Have Therapeutic Potential on TMZ Resistant Glioblastoma".JOURNAL OF BIOMEDICAL NANOTECHNOLOGY 15.7(2019). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论